SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Welcure Drugs & Pharmaceuticals informs about non-applicability of large entities

02 May 2022 Evaluate

Pursuant to SEBI Circular - SEBI/ HO/ DDHS/CIR/ P/ 2018/ 144 dated November 26, 2018, Welcure Drugs & Pharmaceuticals has informed that it enclosed Annual Disclosure for the Financial Year 2021-22 as ‘Annexure B2’. It is informed that there was no incremental borrowing applicable to the company during the financial year 2021-22 as per explanation provided in the aforesaid circular; therefore, the said circular is not applicable on the company.

The above information is a part of company’s filings submitted to BSE.

Welcure Drugs&Pharma Share Price

0.26 0.00 (0.00%)
05-Jun-2026 09:43 View Price Chart
Peers
Company Name CMP
Redington 243.80
Amrapali Industries 18.55
Adani Enterprises 3039.75
Rashi Peripheral 544.55
PDS 319.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×